Autophagy

Autophagy (from Greek auto = self, phagein = to eat) literally means "self-eating". This biological process is an evolutionarily conserved mechanism that enables cells to degrade and recycle their own components. It refers to the breakdown of damaged or dysfunctional organelles and proteins by lysosomal enzymes and the subsequent reuse of their building blocks.

This intracellular process is triggered by various conditions such as physiological stress, starvation, infection and cellular aging. The degradative role of lysosomes in this process is central to maintaining cellular homeostasis.

The concept of autophagy was first defined in the 1960s by Christian de Duve in rat liver cells, where he used the term "self-eating". The molecular mechanisms underlying autophagy were elucidated only in the 1990s through genetic and microscopic studies conducted by Yoshinori Ohsumi.

Ohsumi’s discovery of autophagy-related genes (Atg genes) in yeast cells enabled the identification of the molecular foundations of this process. This breakthrough revealed that autophagy is not merely a simple degradation pathway but a complex, regulated mechanism linked to various diseases.

Autophagy consists of five key stages occurring in a controlled manner within the cell:

1. Initiation: The formation of a membrane structure called the phagophore begins with the activation of the ULK1 complex (ULK1-Atg13-FIP200). This stage is typically triggered by the inhibition of mTORC1.
2. Expansion: During this phase, regulated by the PI3K complex (Beclin-1, Vps34, Atg14, etc.), the phagophore expands by incorporating lipids and begins to engulf target materials.
3. Vesicle Formation: The edges of the phagophore fuse to form a double-membrane structure known as the autophagosome. The conjugation of the Atg8/LC3-II protein to the membrane plays a critical role in this stage.
4. Fusion: The autophagosome fuses with the lysosome via Rab7 and SNARE proteins, exposing its contents to lysosomal enzymes for degradation.
5. Degradation and Recycling: The broken-down macromolecules (amino acids, fatty acids, sugars) are released into the cytoplasm and reused in cellular metabolism.

^{Stage of Mitochondrial Degradation in Autophagy (Generated by Artificial Intelligence)}

Autophagy mechanisms are classified into three main categories:

• Macroautophagy: Organelles and large protein aggregates are degraded through the formation of autophagic vesicles. The attachment of LC3-II protein to the membrane is a defining feature of this process.
• Microautophagy: Small cytosolic components are directly taken up by invagination of the lysosomal membrane.
• Chaperone-Mediated Autophagy: Proteins containing a KFERQ motif bind to the Hsp70 chaperone system and are translocated directly into the lysosome via LAMP-2A. No vesicle formation occurs in this process.

In selective autophagy, specific structures are targeted. For example:

• Mitophagy (mitochondria),
• Ribophagy (ribosomes),
• Pexophagy (peroxisomes),
• Xenophagy (pathogens),
• Aggrephagy (protein aggregates)

Autophagy is essential for maintaining homeostasis, energy production, delaying aging and ensuring cellular quality control. Cells eliminate damaged organelles, toxic proteins and foreign pathogens through this mechanism.

Additionally, autophagy plays a role in Type II programmed cell death. When cells cannot undergo apoptosis, they may die via autophagy. In this way, autophagy has a dual role—both promoting survival and contributing to cell death.

Dysregulation or overactivation of autophagy is linked to numerous diseases:

• Cancer: In some cancer types, autophagy acts as a tumor suppressor; in others, it supports tumor cell survival under nutrient deprivation.
• Neurodegenerative diseases: In conditions such as Alzheimer’s and Parkinson’s disease, impaired degradation of misfolded proteins has made autophagy-targeted therapies increasingly important.
• Metabolic syndromes: Disorders such as diabetes, obesity and insulin resistance are associated with autophagy’s role in energy balance.

Autophagy is activated by prolonged fasting. During starvation, cells begin to break down their own structural components to convert them into energy. In this process, elevated glucagon levels trigger autophagy. Simultaneously, increased growth hormone secretion supports the formation of new cells.

In this context, intermittent fasting regimens may reduce the risk of diseases such as Alzheimer’s and Parkinson’s by promoting autophagy. This process, which encourages cellular renewal, forms the basis of therapeutic fasting approaches in modern biomedical literature.

Autophagy is a fundamental process for cellular balance and health. By participating in energy management and cellular cleansing, it plays a protective role against disease. The regulation of autophagy in molecular biology remains a key area of research for developing novel therapeutic strategies in modern medicine.